OVID.tv
Broadcasting · 11-50 Employees
View Company Info for Free
Overview
Website
www.ovid.tvRevenue
<$5 MillionIndustry
About OVID.tv
OVID.tv Org Chart
Senior Linking Support Engineer
Is OVID.tv your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OVID.tv recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at OVID.tv
Check out if OVID.tv is spiking on competitors!
Funding: Get notified immidiatlly once OVID.tv has new funding data
OVID.tv, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if OVID.tv had a recent Job posting/layoffs
Check if OVID.tv has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when OVID.tv launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined OVID.tv as Masked Content
Find more new buyers
Compare Similar Companies to OVID.tv
Compare insights from companies similar to OVID.tv, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OVID.tv is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
OVID.tv is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about OVID.tv.
OVID.tv financials insights
Gather financial insights about OVID.tv, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$32K
OVID.tv Tech Stack
A closer look at the technologies used by OVID.tv
OVID.tv News & Media
Ovid staff shuffle reads like a who's who of Big Pharma as biotech pivots from Angelman failure
After Ovid Therapeutics’ lead product failed a phase 3 clinical trial in April, CEO Jeremy Levin knew they had some tough work ahead of them. | After Ovid Therapeutics’ lead product failed a phase 3 clinical trial in April, CEO Jeremy Levin knew they had some tough work ahead of them. Now, the biotech has announced a leadership shuffle and staff reductions as it pivots to focus on early-stage development. One thing remains the same:Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results
NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2021.2 Top Biotech Stocks to Buy Under $10
The COVID-19 pandemic brought renewed interest in the biotech industry. Many company's that weren't even working on vaccines or treatments saw their s...
Top Broadcasting Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OVID.tv
OVID is a streaming platform that offers a diverse collection of over 2,300 titles, including documentaries and films. Their library includes works from renowned directors like Godard, Polanski, Bergman, Varda, and Fellini. With content spanning various genres and topics, OVID caters to individuals interested in art, culture, history, social issues... Read More